Xenetic Biosciences, Inc.
XBIO
$2.82
$0.02991.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.57% | -8.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.57% | -8.55% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -0.57% | -8.55% | |||
| SG&A Expenses | 0.18% | -6.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.42% | -12.15% | |||
| Operating Income | 23.13% | 14.26% | |||
| Income Before Tax | 23.74% | 14.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 23.74% | 14.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.74% | 14.36% | |||
| EBIT | 23.13% | 14.26% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 23.74% | 14.36% | |||
| Normalized Basic EPS | 23.74% | 14.37% | |||
| EPS Diluted | 23.74% | 14.36% | |||
| Normalized Diluted EPS | 23.74% | 14.37% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||